Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
International Journal of Laboratory Hematology|May 12, 2012
P2RY1 and P2RY12 polymorphisms and on-aspirin platelet reactivity in patients with coronary artery diseaseA A Timur, G Murugesan, L Zhang, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|October 18, 2011
Two-year vascular hospitalisation rates and associated costs in patients at risk of atherothrombosis in France and Germany: highest burden for peripheral arterial diseaseK G Smolderen, K Wang, G de Pouvourville, et al.
Diabetes, Obesity & Metabolism|August 19, 2014
Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes non-remission status after bariatric surgeryS K Malin, J Bena, B Abood, et al.
European Journal of Preventive Cardiology|August 23, 2013
Geographic differences in outcomes in outpatients with established atherothrombotic disease: results from the REACH RegistryG Ducrocq, D L Bhatt, J Labreuche, et al.
Internal Medicine Journal|September 22, 2015
Subspecialisation in cardiology care and outcome: should clinical services be redesigned, again?B Pathik, C G De Pasquale, A D McGavigan, et al.
Internal Medicine Journal|July 4, 2012
Clinical effectiveness in everyday practice: improving outcomes for all patients through a national acute coronary syndrome data collaborativeC M Astley, A M Tonkin, L J Mahar, et al.
The American Journal of Cardiology|November 17, 1998
Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary interventionD L Bhatt, A M Lincoff, D J Kereiakes, et al.
Heart Asia|June 22, 2016
Risk-factor profile, drug usage and cardiovascular events within a year in patients with and at high risk of atherothrombosis recruited from Asia as compared with those recruited from non-Asian regions: a substudy of the REduction of Atherothrombosis for Continued Health (REACH) registryS Goto, Y Ikeda, J C N Chan, et al.
Circulation|December 22, 1999
Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudyS P Marso, A M Lincoff, S G Ellis, et al.
International Journal of Obesity (2005)|October 30, 2013
Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapyS K Malin, A Samat, K Wolski, et al.
Pageof 8